Creating sophisticated gene
therapy solutions to treat
complex eye diseases

Explore

We are on a mission to treat common causes of sight-loss with advanced gene therapy

Normal Vision
Central Vision Loss
1 in 10
people aged 50+ have early signs of AMD
Discovering new therapies

Treating Age-Related Macular Degeneration

Age-Related Macular Degeneration (AMD) is the leading cause of irreversible vision loss in individuals over 60 years of age.

The condition starts as Dry AMD and as central vision gradually deteriorates it becomes increasingly difficult to read and recognize faces. Wet AMD develops in 10-15% of cases and if left untreated, can lead to very sudden and significant vision loss. The global number of people with AMD is projected to be 288M by 2040

Learn more about AMD
Who we are

Ikarovec is a leader in ophthalmology innovation, with sophisticated, field-changing technology for the long-term relief of prevalent eye diseases

Ikarovec is advancing a pipeline of next generation gene therapies to treat major chronic eye diseases. For patients, Ikarovec’s products will mean continuous life-long sight preservation, freeing them from current burdensome, repetitive treatments with one single injection.
Learn more about us
Novel Therapies

Building novel bi-functional gene therapies to treat sight loss

Ikarovec’s innovative bi-functional gene therapy delivers genetic instructions for two clinically relevant proteins that each target different aspects of the disease, addressing multiple pathways involved in its progression. This approach offers a superior therapeutic advantage over single-target treatments for the growing population affected by ophthalmic diseases.
Learn more about our Technology

What is gene therapy?

Gene therapy is a sophisticated medical technique designed to deliver genetic information directly into a patient’s target cells, allowing for the treatment or prevention of diseases at their root causes.

Why treat sight loss?

Addressing sight loss not only improves quality of life but also reduces the physical, emotional, and social challenges associated with visual impairment, fostering independence and inclusivity.

Why bi-functional?

Bi-functional gene therapy offers a powerful advantage by delivering two therapeutic effects at once, enabling a more effective approach to treating diseases with complex underlying causes.

What is gene therapy?

Gene therapy is a sophisticated medical technique designed to deliver genetic information directly into a patient’s target cells, allowing for the treatment or prevention of diseases at their root causes.

Why treat sight loss?

Addressing sight loss not only improves quality of life but also reduces the physical, emotional, and social challenges associated with visual impairment, fostering independence and inclusivity.

Why bi-functional?

Bi-functional gene therapy offers a powerful advantage by delivering two therapeutic effects at once, enabling a more effective approach to treating diseases with complex underlying causes.
Background object

Partner with Ikarovec

Join us in transforming ophthalmic care—contact us to explore opportunities to collaborate.
Reach out